Three new synthetic progestins in the treatment of endometriosis

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (11)

• Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis 2001
• Progestins for symptomatic endometriosis: a critical analysis of the evidence 1997
• Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome 1997
• Medical management of endometriosis 1993
• Gestogens and anti-gestogens as treatment of endometriosis 1991
• Hormonal and Surgical Management of Pelvic Endometriosis 1982
• The surgical treatment of endometriosis 1978
• Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of posttreatment fertility and three-year follow-up data 1978
• Management of endometriosis in the infertile patient 1975
• The prevention, inhibition, palliation, and treatment of endometriosis 1975
• Colorectal endometriosis 1973

Source provenance

europepmc

last seen: 2026-10-19T06:17:24.038039+00:00

openalex

last seen: 2026-06-04T00:00:01.174412+00:00

pubmed

last seen: 2026-10-08T21:57:54.098323+00:00